Eledon Pharmaceuticals, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Eledon Pharmaceuticals, Inc. (ELDN) is 207.15M

According to Eledon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 207.15M. This represents a change of -22.61% compared to the average of 267.67M of the last 4 quarters.

Eledon Pharmaceuticals, Inc. (ELDN) Historical Enterprise Value (quarterly & annually)

How has ELDN Enterprise Value performed in the past?

The mean historical Enterprise Value of Eledon Pharmaceuticals, Inc. over the last ten years is 172.37M. The current 207.15M Enterprise Value has changed 20.17% with respect to the historical average. Over the past ten years (40 quarters), ELDN's Enterprise Value was at its highest in in the June 2018 quarter at 1.17B. The Enterprise Value was at its lowest in in the June 2022 quarter at -35065191.80.

Eledon Pharmaceuticals, Inc. (ELDN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Eledon Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Eledon Pharmaceuticals, Inc. (ELDN) Average Enterprise Value

How has ELDN Enterprise Value performed in the past?

The current Enterprise Value of Eledon Pharmaceuticals, Inc. (ELDN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Eledon Pharmaceuticals, Inc. (ELDN) Enterprise Value vs. Peers

How is ELDN’s Enterprise Value compared to its peers?

Eledon Pharmaceuticals, Inc.’s Enterprise Value is less than Puma Biotechnology, Inc. (501.77M), greater than Abeona Therapeutics Inc. (203.53M), less than Allogene Therapeutics, Inc. (412.22M), greater than Vanda Pharmaceuticals Inc. (185.72M), less than Atea Pharmaceuticals, Inc. (247.92M), greater than Voyager Therapeutics, Inc. (103.71M), greater than Entrada Therapeutics, Inc. (129.54M), greater than Humacyte, Inc. (96.45M), less than Achieve Life Sciences, Inc. (629.16M), less than Editas Medicine, Inc. (239.92M),

Build a custom stock screener for Eledon Pharmaceuticals, Inc. (ELDN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eledon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eledon Pharmaceuticals, Inc. (ELDN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eledon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.